A detailed history of J. Safra Sarasin Holding Ag transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 73,577 shares of APLS stock, worth $2.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
73,577
Previous 37,543 95.98%
Holding current value
$2.04 Million
Previous $1.44 Billion 47.34%
% of portfolio
0.04%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$28.84 - $41.15 $1.04 Million - $1.48 Million
36,034 Added 95.98%
73,577 $2.12 Billion
Q2 2024

Jul 30, 2024

BUY
$38.07 - $59.71 $1.43 Million - $2.24 Million
37,543 New
37,543 $1.44 Billion

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.05B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.